Novel Approaches to Protein Degradation Pathways in Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
CCO’s Conference to Clinic Highlights From ASH 2024 Annual Meeting: Multiple Myeloma

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
CCO’s Conference to Clinic Highlights From ASH 2024 Annual Meeting: Multiple Myeloma

Content Format:

Slideset

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
An Expert’s Guide to ASH 2024: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Conference to Clinic: Expert Analysis of the Top Multiple Myeloma Abstracts From the 2023 ASH Annual Meeting

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Conference to Clinic: Expert Analysis of the 2023 ASH Top Abstracts

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

4.75
Conference to Clinic: Multiple Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2023: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Updates in Multiple Myeloma Care: Expert Guidance for the Multidisciplinary Teams in VHA Systems

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Multiple Myeloma: Diagnosis and Treatment for 2023

Content Format:

PDF

Credit Type:

--

Credits:

--
An Interactive Decision Support Tool: Treatment Options From 5 Experts for People With Multiple Myeloma

Content Format:

Tool

Credit Type:

--

Credits:

--
Current and Emerging Therapeutic Strategies Targeting BCMA for Relapsed/Refractory Multiple Myeloma: Guidance for the Community Multidisciplinary Team

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Current and Emerging Therapeutic Strategies Targeting BCMA for Relapsed/Refractory Multiple Myeloma: Guidance for the Community Multidisciplinary Team

Content Format:

Slideset

Credit Type:

--

Credits:

--
BCMA-Targeting Agents in Relapsed/Refractory Multiple Myeloma: Current Approved Indications and General Management of Toxicities

Content Format:

PDF

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Recommendations on Treatment for Multiple Myeloma

Content Format:

Tool

Credit Type:

--

Credits:

--
Key Studies in Multiple Myeloma: Independent Conference Coverage of ASH 2022

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
An Expert’s Guide to ASH 2022: Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Perspectives on the Treatment of Multiple Myeloma in the Relapse Setting: Case Discussion and Common Clinical Scenarios

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Managing Multiple Myeloma in the Relapsed Setting: Expert Perspectives on Recent Advances

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Perspectives on the Treatment of Multiple Myeloma In The Relapse Setting: Case Discussion and Common Clinical Scenarios

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Experts Discuss the Evolution of CAR T-Cell Therapy in Multiple Myeloma

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Investigational CAR T-Cell Therapies in Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in Multiple Myeloma: Independent Conference Coverage of ASH 2021

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
BCMA-Targeted Bispecific Antibodies: A New Approach for Relapsed/Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2021: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
FAQs on the Use of BCMA-Targeted Therapies for Relapsed or Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Next-Generation Therapeutic Strategies for Relapsed/Refractory Multiple Myeloma: Targeting BCMA

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
ExpressPointsNext-Generation Therapeutic Strategies for Relapsed/Refractory Multiple Myeloma: Targeting BCMA

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
BCMA-Targeted Antibody–Drug Conjugates in Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Current Strategies for Targeting BCMA in R/R Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Advances in R/R Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Content Format:

Multimedia

Credit Type:

ACPE

Credits:

1.00
ExpressPoints Advances in Relapsed/Refractory Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Advances in Relapsed/Refractory Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in Myeloma: CCO Independent Conference Highlights of the 2020 Virtual ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
Expert Insights on Highlights From ASH 2020 on Multiple Myeloma

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Expert Selections From ASH 2020: Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Answering Your Questions: Ocular Toxicity With Antibody–Drug Conjugates

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Mitigation and Management of Ocular Toxicity in Patients Receiving Antibody–Drug Conjugates

Content Format:

Multimedia

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2020: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Treatment Options From 5 Experts for People With Multiple Myeloma: An Interactive Decision Support Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance on Current and Future Therapeutic Strategies for Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Expert Guidance on Therapeutic Strategies for Multiple Myeloma

Content Format:

Text Module

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Insight on Treatment Options for Multiple Myeloma

Content Format:

Tool

Credit Type:

--

Credits:

--
New Insights in Hematologic Malignancies and Disorders: Independent Conference Coverage of the 2019 ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
My Thoughts on Key Studies in Myeloma From ASH 2019

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Preview of ASH 2019: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

1.00
Understanding the Latest Therapeutic Advances in Multiple Myeloma: Expert Guidance and Implications for Treatment Decisions

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Preview of Hot Topics at ASH 2018: Key Expert-Selected Studies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--